5-Amino-1MQ 50mg

5-Amino-1MQ is a small molecule inhibitor of NNMT (Nicotinamide N-methyltransferase) — an enzyme that is dramatically upregulated in obese adipose tissue and plays a previously underappreciated role in obesity, metabolic disease, and cellular aging. By blocking NNMT, 5-Amino-1MQ restores NAD+ and methyl group availability in fat cells, activating SIRT1 and reversing the metabolic dysfunction that drives fat cell expansion.

NNMT: The Obesity Enzyme

NNMT catalyzes the methylation of nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as the methyl donor — producing 1-methylnicotinamide and S-adenosylhomocysteine. This reaction consumes two critical metabolic resources simultaneously: 1. Nicotinamide → consumed, reducing NAD+ production from this precursor pathway 2. SAM methyl groups → consumed, reducing methyl availability for DNA methylation and other critical reactions

NNMT is highly expressed in white adipose tissue, liver, and skeletal muscle, and its expression increases dramatically in obesity. Research has identified NNMT as a key driver of the metabolic dysfunction in obese adipose tissue: - Obese subjects have 2–6× higher NNMT expression in adipose vs. lean subjects - High NNMT depletes NAD+ in fat cells → impairs SIRT1 → promotes fat storage over metabolism - NNMT upregulation in adipose tissue creates a metabolic environment that favors further weight gain

The NAD+ Connection

Nicotinamide is a precursor for NAD+ production via the nicotinamide salvage pathway. When NNMT diverts nicotinamide to 1-methylnicotinamide instead, less NAD+ is produced in that tissue. In adipose tissue, reduced NAD+ availability impairs sirtuin enzymes — SIRT1, SIRT3, SIRT6 — that regulate fat cell metabolism, lipolysis, and mitochondrial function.

5-Amino-1MQ blocks NNMT, allowing nicotinamide to enter the NAD+ biosynthesis pathway instead — restoring NAD+ in fat cells and reactivating sirtuin-mediated fat metabolism.

Animal Study Evidence

The landmark 5-Amino-1MQ studies from the University of Texas Health Science Center: - Obese mice given 5-Amino-1MQ showed significant reduction in fat cell size and fat mass - Treatment prevented diet-induced obesity when started prophylactically - Reduction in total body fat without caloric restriction - Increased NAD+ levels and SIRT1 activity in adipose tissue confirmed in tissue analysis - No adverse effects on lean mass, organ function, or metabolic markers

SAM Methyl Group Conservation

Beyond NAD+, blocking NNMT conserves SAM methyl groups. SAM is the universal methyl donor in biology — it methylates DNA (epigenetic regulation), histones (gene regulation), neurotransmitters (catecholamine synthesis), and proteins. In high-NNMT states, excessive SAM consumption for nicotinamide methylation depletes methyl availability for these other critical reactions. 5-Amino-1MQ preserves the methyl pool, with potential downstream benefits for epigenetic regulation and neurotransmitter synthesis.